Início › Câncer de Pulmão de Não Pequenas Células › Ohio › Akron
Ensaios clínicos de Câncer de Pulmão de Não Pequenas Células em Akron, OH
22 estudos para Câncer de Pulmão de Não Pequenas Células estão buscando participantes em locais em Akron e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecrutandoFase 3
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · a 21 mi de distância
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecrutandoFase 3
- Aultman Health Foundation, Canton · a 21 mi de distância
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RecrutandoFase 3
- Akron General Medical Center, Akron
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecrutandoFase 3
- Aultman North, North Canton · a 15 mi de distância
- Aultman Massillon, Massillon · a 20 mi de distância
- Aultman Orrville Hospital, Orrville · a 21 mi de distância
- e mais 2
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
RecrutandoFase 3
- Research Site, Canton · a 21 mi de distância
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RecrutandoFase 3
- Aultman Hospital, Canton · a 21 mi de distância
Pan-tumor MRD Study
RecrutandoEstudo observacional
- Gabrail Cancer Center, Canton · a 21 mi de distância
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RecrutandoFase 2/3
- Gabrail Cancer Center Research, Canton · a 21 mi de distância
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
RecrutandoFase 2
- Gabrail Cancer Center, Canton · a 21 mi de distância
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecrutandoFase 2/3
- Tricounty Hematology and Oncology - Massillon, Massillon · a 20 mi de distância
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
RecrutandoFase 1/2
- Gabrail Cancer Center Research, Canton · a 21 mi de distância
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RecrutandoFase 3
- Gabrail Cancer Center, Canton · a 21 mi de distância
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RecrutandoFase 2
- Gabrail Cancer and Research Center, Canton · a 21 mi de distância
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecrutandoFase 2
- Cleveland Clinic Mercy Hospital, Canton · a 21 mi de distância
- Aultman Health Foundation, Canton · a 21 mi de distância
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- Aultman Health Foundation, Canton · a 21 mi de distância
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- Aultman Health Foundation, Canton · a 21 mi de distância
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2/3
- Aultman Health Foundation, Canton · a 21 mi de distância
GEMINI-NSCLC: NSCLC Biomarker Study
RecrutandoEstudo observacional
- Aultman Hospital, Canton · a 21 mi de distância
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RecrutandoFase 1
- Gabrail Cancer & Research Center, Canton · a 21 mi de distância
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecrutandoFase 1/2
- Research Site 138, Canton · a 21 mi de distância
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
RecrutandoFase 1/2
- Gabrail Cancer Center Research, Canton · a 21 mi de distância
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
RecrutandoFase 1/2
- Gabrail Cancer Research Center, Canton · a 21 mi de distância
Ensaios de Câncer de Pulmão de Não Pequenas Células em outras cidades
- Houston, TX145 estudos
- New York City, NY120 estudos
- Arlington, VA104 estudos
- Nashville, TN97 estudos
- Boston, MA90 estudos
- Los Angeles, CA87 estudos
- St. Louis, MO73 estudos
- Chicago, IL61 estudos
- Baltimore, MD60 estudos
- San Antonio, TX59 estudos
- Columbus, OH56 estudos
- Washington, DC55 estudos
Outros estudos em Akron
- Câncer de Pulmão16 estudos
- Câncer (todos os tipos)13 estudos
- Câncer de Mama13 estudos
- Câncer de Próstata9 estudos
- Leucemia Mieloide Aguda8 estudos
- Melanoma8 estudos
- Câncer de Pulmão de Células Pequenas8 estudos
- Câncer Metastático8 estudos
- Câncer Colorretal8 estudos
- Doença Hepática Esteatótica7 estudos
- Câncer Endometrial6 estudos
- Câncer de Ovário6 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.